Surgery Partners Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.8%projected annual EPS growth
Analyst Coverage
11analysts covering
FY Revenue (est.)
$3.4Bnext fiscal year
FY EPS (est.)
$0.49next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 10 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Same-Facility Revenue Growth Quarterly440.0%Target: Positive organic growth
Same-Facility Case Volume Growth Quarterly60.0%Target: Positive volume expansion
Same-Facility Revenue Per Case Growth Quarterly380.0%Target: Reflecting higher-acuity procedure mix
Adjusted EBITDA Quarterly102.3MTarget: At least 530000000
Watch Items
- Payer Mix and Reimbursement PressuresTrigger: Unfavorable shift in commercial vs. government payer mixAction: Optimize case scheduling and renegotiate commercial contracts to protect margins.
- Anesthesia and Provider Cost InflationTrigger: Headwinds exceeding $8 million from provider tax and Medicaid pressuresAction: Implement cost-containment initiatives and enhance operational efficiencies.
- Leverage and Debt Service CostsTrigger: Net debt to EBITDA ratio exceeding 4.3xAction: Prioritize free cash flow generation, evaluate non-core asset divestitures, and limit aggressive debt-funded M&A.
Research as of 20 Jun 2026